N. Zariffa

The ABC of pharmaceutical trial design: some basic principles

S. Julious, N. Zariffa, N. Zariffa, 2002 .

Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases.

J. Danesh, R. Collins, A. Hofman, 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Non-traditional study designs to demonstrate average bioequivalence for highly variable drug products

S. Patterson, T. Montague, N. Zariffa, 2001, European Journal of Clinical Pharmacology.

Streamlining cardiovascular clinical trials to improve efficiency and generalisability

Deepak L. Bhatt, D. Madigan, M. Pfeffer, 2017, Heart.

PhRMA Perspective on Population and Individual Bioequivalence

A. Gould, J. Barrett, A. Chow, 2000, Journal of clinical pharmacology.

The New Drug Approvals of 1996, 1997, & 1998: Drug Development Trends in The User Fee Era

N. Zariffa, Scott D. Patterson, D. Boyle, 1999, Statistics in medicine.